NYSE: BSX
Boston Scientific Corporation
Healthcare · Medical - Devices
Market Cap
$78.30B
52w High
$109.50
52w Low
$52.52
P/E
22.02
Volume
14.80M
Outstanding Shares
1.49B
Valuation Data Insufficient
The DCF model's fair value estimate is more than 3× the current stock price. This typically indicates unreliable model inputs — such as irregular cash flows or balance sheet distortions — rather than a genuine opportunity, so the valuation is not shown.
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 49.76% over the last year. Revenue grew 17.44% over the trailing twelve months. Operating margin moved from 16.56% to 20.12%. Free cash flow grew 19.81% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price, and the shares now sit around the 0th percentile of their historical P/FCF range. That looks more like a rerating of the multiple than a collapse in the business.
What would invalidate this read
This read changes if operating margin (currently 20.12%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Valuation
Stock splits
Every 1 shares became 2
Every 1 shares became 2
Profitability & growth
Analyst consensus
40
Buy
3
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 29, 2026
Q3 FY26 · EPS est $0.84 · Revenue est $5.4B
View
Congressional Activity
Congress Trades in BSX
STOCK Act disclosures from senators and representatives.
Michael McCaul
TXhouseRepublicanPurchaseSpouse2026-03-27$1,001 - $15,000+14d to disclose
Markwayne Mullin
OKsenateRepublicanPurchaseJoint2025-12-29$15,001 - $50,000+17d to disclose
John Boozman
ARsenateRepublicanSale (Partial)Joint2025-12-17$1,001 - $15,000+26d to discloseJohn Boozman
ARsenateRepublicanSaleJoint2025-12-17$1,001 - $15,000+27d to disclose